LLY 禮來

813.48
11.83
(1.48%)

禮來 LLY

單位：USD
813.48
11.83
(1.48%)
製藥
成交股數
307萬
本益比
72.83
市值 7306.43億
報價時間 | -
單位：美金千元
科目 2024/Q4 2024/Q3 2024/Q2 2024/Q1 2023/Q4 2023/Q3 2023/Q2 2023/Q1 2022/Q4 2022/Q3 2022/Q2 2022/Q1 2021/Q4 2021/Q3 2021/Q2 2021/Q1 2020/Q4 2020/Q3 2020/Q2 2020/Q1
營業收入淨額
13,532,800 11,439,100 11,302,800 8,768,000 9,353,400 9,498,600 8,312,100 6,960,000 7,301,800 6,941,600 6,488,000 7,810,000 7,999,900 6,772,800 6,740,100 6,805,600 7,440,000 5,740,600 5,499,400 5,859,800
營業成本
2,403,800 2,170,800 2,170,200 1,673,500 1,788,000 1,860,100 1,807,400 1,626,700 1,548,100 1,579,100 1,430,500 2,072,100 2,050,200 1,430,800 1,953,200 1,878,600 1,719,800 1,326,400 1,222,000 1,215,100
營業毛利
11,129,000 9,268,300 9,132,600 7,094,500 7,565,400 7,638,500 6,504,700 5,333,300 5,753,700 5,362,500 5,057,500 5,737,900 5,949,700 5,342,000 4,786,900 4,927,000 5,720,200 4,414,200 4,277,400 4,644,700
營業費用
5,980,200 7,741,900 5,417,800 4,585,500 5,177,600 7,188,100 4,379,000 3,839,300 3,917,300 3,686,000 3,847,400 3,333,600 4,032,500 3,460,800 3,383,500 3,771,700 3,728,100 3,135,900 3,080,600 3,053,900
研發費用
3,022,500 2,734,100 2,711,200 2,522,800 2,562,700 2,409,100 2,356,500 1,985,100 1,995,900 1,802,900 1,781,900 1,610,100 1,993,500 1,739,400 1,685,500 1,684,800 1,838,000 1,465,400 1,390,200 1,392,100
推銷及管理費用
2,424,500 2,099,800 2,117,300 1,952,200 1,924,600 1,803,900 1,925,400 1,749,200 1,643,200 1,614,200 1,625,100 1,557,900 1,592,000 1,577,900 1,685,700 1,576,000 1,553,900 1,569,100 1,448,600 1,549,600
非經常性項目費用
533,200 2,908,000 589,300 110,500 690,300 2,975,100 97,100 105,000 278,200 268,900 440,400 165,600 447,000 143,500 12,300 510,900 336,200 101,400 241,800 112,200
其他營業費用
- - - - - - - - - - - - - - - - - - - 0
營業利益
5,148,800 1,526,400 3,714,800 2,509,000 2,387,800 450,400 2,125,700 1,494,000 1,836,400 1,676,500 1,210,100 2,404,300 1,917,200 1,881,200 1,403,400 1,155,300 1,992,100 1,278,300 1,196,800 1,590,800
其他收入及費用
-110,100 62,000 -197,600 27,100 121,000 -23,200 -36,800 35,700 260,000 -111,000 -119,200 -350,700 -77,300 -635,900 190,500 321,100 477,000 158,900 446,900 89,100
利息費用
- - - - - - - - - - - - - - - - - - - 0
稅前純益
5,038,700 1,588,400 3,517,200 2,536,100 2,508,800 427,200 2,088,900 1,529,700 2,096,400 1,565,500 1,090,900 2,053,600 1,839,900 1,245,300 1,593,900 1,476,400 2,469,100 1,437,200 1,643,700 1,679,900
所得稅
628,900 618,100 550,200 293,200 319,100 484,600 325,700 184,800 158,700 113,800 138,400 150,700 113,800 135,200 203,700 121,100 352,300 228,800 231,700 223,400
稅後純益
4,409,800 970,300 2,967,000 2,242,900 2,189,700 -57,400 1,763,200 1,344,900 1,937,700 1,451,700 952,500 1,902,900 1,726,100 1,110,100 1,390,200 1,355,300 2,116,800 1,208,400 1,412,000 1,456,500
基本每股稅後盈餘(元)
4.91 1.08 3.3 2.49 2.43 -0.06 1.86 1.42 2.04 1.61 1.06 2.11 1.81 1.16 1.53 1.41 2.21 1.26 1.48 1.52
稀釋每股稅後盈餘(元)
4.88 1.07 3.28 2.48 2.42 -0.06 1.95 1.49 2.14 1.6 1.06 2.1 1.89 1.22 1.52 1.49 2.32 1.32 1.55 1.6
基本平均股數(千股)
897,538 899,850 900,416 900,403 899,379 949,303 949,286 949,267 950,182 900,700 900,300 903,700 953,653 956,589 907,300 959,482 956,590 956,491 956,466 956,929
稀釋平均股數(千股)
903,158 905,027 904,248 903,802 903,980 949,303 949,286 949,267 950,182 903,800 902,900 906,400 953,653 956,589 910,400 959,482 956,590 956,491 956,466 956,929
還原基本每股稅後盈餘(元)
4.91 1.08 3.3 2.49 2.43 -0.06 1.86 1.42 2.04 1.61 1.06 2.11 1.81 1.16 1.53 1.41 2.21 1.26 1.48 1.52
還原稀釋每股稅後盈餘(元)
4.88 1.07 3.28 2.48 2.42 -0.06 1.95 1.49 2.14 1.6 1.06 2.1 1.89 1.22 1.52 1.49 2.32 1.32 1.55 1.6
還原基本平均股數(千股)
897,538 899,850 900,416 900,403 899,379 949,303 949,286 949,267 950,182 900,700 900,300 903,700 953,653 956,589 907,300 959,482 956,590 956,491 956,466 956,929
還原稀釋平均股數(千股)
903,158 905,027 904,248 903,802 903,980 949,303 949,286 949,267 950,182 903,800 902,900 906,400 953,653 956,589 910,400 959,482 956,590 956,491 956,466 956,929
EBITDA(千元)
5,523,500 2,055,200 3,931,600 2,936,700 2,896,500 838,200 2,455,200 1,892,000 2,471,400 1,928,400 1,439,800 2,489,300 2,285,600 1,627,600 1,963,200 1,826,700 2,836,600 1,795,600 1,968,100 1,953,500